Source: Annual Congress 2004 - Primary care: asthma, allergy and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. S. Breekveldt-Postma, A. F. C. Janse, R. Sandtmann, L. E. Melilli, R. M. C. Herings (Utrecht, The Netherlands; Konstanz, Germany; New York, United States Of America). Drug use profiles before, during and after hospitalization for chronic obstructive pulmonary disease in the Netherlands. Eur Respir J 2004; 24: Suppl. 48, 631

Member's Comments

No comment yet.

Related content which might interest you: Trends in healthcare utilization and costs prior to a chronic obstructive pulmonary disease (COPD) diagnosis Source: Eur Respir J 2006; 28: Suppl. 50, 36s Year: 2006 Costs of chronic obstructive pulmonary disease in Sweden Source: Eur Respir J 2002; 20: Suppl. 38, 125s Year: 2002 Drug prescribing and burden of asthma and chronic obstructive pulmonary disease (COPD): a study from Italian general practitioners Source: Eur Respir J 2005; 26: Suppl. 49, 672s Year: 2005 Prescription of opioids for breathlessness in end-stage chronic obstructive pulmonary disease: A national population based study Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 903-908 Year: 2001 Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 Antibiotic use for hospitalized chronic obstructive pulmonary disease exacerbations: A propensity adjusted analysis Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Treatment patterns of patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 795-798 Year: 2003 Bacterial profile of acute infectious exacerbations of chronic obstructive pulmonary disease requiring hospitalization in Greece Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Source: Eur Respir J 2002; 19: 966-975 Year: 2002 Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Disease severity and complexity in patients with acute exacerbation of chronic obstructive pulmonary disease in Lazio, Italy Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Improvement of diagnosis and treatment of obstructive lung diseases with a one stop diagnostic consultancy Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006 Proactive integrated care improves quality of life in patients with COPD Source: Eur Respir J 2009; 33: 1031-1038 Year: 2009 Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 Safety of early supported discharge in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and low oxygen Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Use of antibiotics in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Prolonging the interval to the next acute exacerbations Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005